Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sensitivity and specificity of intranasal provocation].

C Bachert1, A Keilmann

  • 1Hals-Nasen-Ohren-Klinik, Klinikum Mannheim der Universität Heidelberg.

Laryngologie, Rhinologie, Otologie
|February 1, 1988
PubMed
Summary
This summary is machine-generated.

Standardizing the nasal provocation test (NPT) requires high allergen concentrations for accurate grass allergy diagnosis. Optimal NPT sensitivity and specificity were achieved using 100,000-150,000 BE/ml allergen concentrations.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The new Mainz Audiometric Test for Children aged 3-7 years (MATCH) in noise : Design, normalization, and validation].

HNO·2026
Same author

Real-world effectiveness of omalizumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP): findings from CHRINOSOR.

Rhinology·2026
Same author

Indication for biologics in a real-world cohort of dupilumab treated chronic rhinosinusitis with nasal polyps patients according to international recommendations: evidence from the European CRS Outcome Registry (CHRINOSOR).

Rhinology·2025
Same author

The alphaherpesvirus gE/gI glycoprotein complex and proteases jointly orchestrate invasion across the host's upper respiratory epithelial barrier.

mBio·2024
Same author

The impact of mepolizumab on sleep impairment in CRSwNP: post hoc analyses of SYNAPSE and MUSCA.

Rhinology·2024
Same author

Mepolizumab in CRSwNP/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and Russia.

Rhinology·2024

Area of Science:

  • Allergen immunotherapy
  • Clinical immunology
  • Allergic rhinitis research